PDF
ePub
Citation
Print
Abstract
Dietary counseling and oral nutritional supplements (ONS) should be considered to increase the nutritional intake of people malnourished or at risk of malnutrition. These supplements are typically ready-made liquids and contain a balanced mix of energy, protein, and micronutrients. The diabetes-specific ONS are specifically designed for patients with hyperglycemia or diabetes mellitus in order to provide better glycemic control such as postprandial glucose and HbA1c compared to the standard ONS. These supplements are lower in carbohydrates and higher in fat than standard supplements and are rich in monounsaturated fats. Using diabetes-specific ONS in malnourished diabetic patients can allow increasing energy intake while maintaining glucose control and improving nutritional status and also providing economic benefits. However, inadequate intake of ONS that do not fit the patient's condition can be a problem. Therefore, when using ONS for patients with diabetes, it is necessary to clinically evaluate the nutritional status of the patient and to provide individualized education and management accordingly.
References
1. Ministry of Food and Drug Safety. Korean Food Standards Codex. Available from:. http://www.foodsafetykorea.go.kr/foodcode/01_03.jsp?idx=51. (updated 2016 Dec 19).
2. Nieuwenhuizen WF, Weenen H, Rigby P, Hetherington MM. Older adults and patients in need of nutritional support: review of current treatment options and factors influencing nutritional intake. Clin Nutr. 2010; 29:160–9.
3. Capitini N, Montanari L, Marotta GG, Morucci R. Elderly nursing home residents, risk of malnutrition, and nutritional supplements: our experience. Nutr Ther Metab. 2011; 29:150.
4. Cawood AL, Elia M, Stratton RJ. Systematic review and metaanalysis of the effects of high protein oral nutritional supplements. Ageing Res Rev. 2012; 11:278–96.
5. Mayr P, Kuhn KS, Klein P, Stover JF, Pestana EA. A diabetes-specific oral nutritional supplement improves glycaemic control in type 2 diabetes patients. Exp Clin Endocrinol Diabetes. 2016; 124:401–9.
6. OH YT, Kim SH, Kim CH, Lee SY, Jang HS, Cho SM, Choi YY, Choi WS, Yun SS. The effect of oral high protein liquid on nutritional support in patients undergoing radiotherapy for head and neck cancer. Korean J Head Neck Oncol. 2008; 24:184–8.
7. Baldwin C, Spiro A, Ahern R, Emery PW. Oral nutritional interventions in malnourished patients with cancer: a systematic review and metaanalysis. J Natl Cancer Inst. 2012; 104:371–85.
8. Lee J, Park JC, Jung UW, Choi SH, Cho KS, Park YK, Kim CS. Improvement in periodontal healing after periodontal surgery supported by nutritional supplement drinks. J Periodontal Implant Sci. 2014; 44:109–17.
9. Kim HS, Cho IW, Shin HS, Park JC. Patient-reported outcome measures on intake of nutrition drink for nutritional supplements after periodontal surgery. J Dent Rehabil Appl Sci. 2016; 32:176–83.
10. National Collaborating Centre for Acute Care (Great Britain); National Institute for Clinical Excellence (Great Britain). Nutrition support in adults: oral nutrition support, enteral tube feeding and parenteral nutrition. London: National Collaborating Centre for Acute Care;2006.
11. Mueller C, McClave S, Kuhn JM. The A.S.P.E.N. adult nutrition support core curriculum. Silver Spring, MD: American Society for Parenteral and Enteral Nutrition;2012.
12. Hise ME, Fuhman MP. The effect of diabetes-specific enteral formulae on clinical and glycemic indicators. Pract Gastroenterol. 2009. 20–36.
13. Korean Diabetes Association Education Committee. The guide for diabetes education. 3rd ed.Seoul: Gold' Planning and Development;2013. p. 63–4.
14. König D, Theis S, Kozianowski G, Berg A. Postprandial substrate use in overweight subjects with the metabolic syndrome after isomaltulose (Palatinose™) ingestion. Nutrition. 2012; 28:651–6.
15. Wolever TM, Gibbs AL, Chiasson JL, Connelly PW, Josse RG, Leiter LA, Maheux P, Rabasa-Lhoret R, Rodger NW, Ryan EA. Altering source or amount of dietary carbohydrate has acute and chronic effects on postprandial glucose and triglycerides in type 2 diabetes: Canadian trial of carbohydrates in diabetes (CCD). Nutr Metab Cardiovasc Dis. 2013; 23:227–34.
16. Mori Y, Ohta T, Tanaka T, Morohoshi Y, Matsuura K, Yokoyama J, Utsunomiya K. Effects of a low-carbohydrate diabetes-specific formula in type 2 diabetic patients during tube feeding evaluated by continuous glucose monitoring. E Spen Eur E J Clin Nutr Metab. 2011; 6:e68–73.
17. Devitt AA, Williams JA, Choe YS, Hustead DS, Mustad VA. Glycemic responses to glycemia-targeted specialized-nutrition beverages with varying carbohydrates compared to a standard nutritional beverage in adults with type 2 diabetes. Adv Biosci Biotechnol. 2013; 4:1–10.
18. Ministry of Food and Drug Safety. Drug Administration: approval of functional ingredient of health functional foods in Korea. Cheongju: Ministry of Food and Drug Safety;2016.
19. Kim S. Sources and formulation of m- and micronutrients in enteral nutrition formula. J Clin Nutr. 2016; 8:45–50.
20. Luiking YC, Deutz NE, Jäkel M, Soeters PB. Casein and soy protein meals differentially affect whole-body and splanchnic protein metabolism in healthy humans. J Nutr. 2005; 135:1080–7.
21. Paul GL. The rationale for consuming protein blends in sports nutrition. J Am Coll Nutr. 2009; 28(Suppl):464S–72S.
22. Imamura F, Micha R, Wu JH, de Oliveira Otto MC, Otite FO, Abioye AI, Mozaffarian D. Effects of saturated fat, polyunsaturated fat, monounsaturated fat, and carbohydrate on glucose-insulin homeostasis: a systematic review and metaanalysis of randomised controlled feeding trials. PLoS Med. 2016; 13:e1002087.
23. de Luis DA, Izaola O, Aller R, Cuellar L, Terroba MC, Martin T, Cabezas G, Rojo S, Domingo M. A randomized clinical trial with two enteral diabetes-specific supplements in patients with diabetes mellitus type 2: metabolic effects. Eur Rev Med Pharmacol Sci. 2008; 12:261–6.
24. Ojo O, Brooke J. Evaluation of the role of enteral nutrition in managing patients with diabetes: a systematic review. Nutrients. 2014; 6:5142–52.
25. Qian F, Korat AA, Malik V, Hu FB. Metabolic effects of monounsaturated fatty acid-enriched diets compared with carbohydrate or polyunsaturated fatty acid-enriched diets in patients with type 2 diabetes: a systematic review and metaanalysis of randomized controlled trials. Diabetes Care. 2016; 39:1448–57.
26. Lansink M, van Laere KM, Vendrig L, Rutten GE. Lower postprandial glucose responses at baseline and after 4 weeks use of a diabetes-specific formula in diabetes type 2 patients. Diabetes Res Clin Pract. 2011; 93:421–9.
27. Hofman Z, Lansink M, Rouws C, van Druen JDE, Kuipers H. Diabetes specific tube feed results in improved glycaemic and triglyceridaemic control during 6h continuous feeding in diabetes patients. E Spen Eur E J Clin Nutr Metab. 2007; 2:44–50.
28. Alish CJ, Garvey WT, Maki KC, Sacks GS, Hustead DS, Hegazi RA, Mustad VA. A diabetes-specific enteral formula improves glycemic variability in patients with type 2 diabetes. Diabetes Technol Ther. 2010; 12:419–25.
29. Mesejo A, Montejo-González JC, Vaquerizo-Alonso C, Lobo-Tamer G, Zabarte-Martinez M, Herrero-Meseguer JI, Acosta-Escribano J, Blesa-Malpica A, Martinez-Lozano F. Diabetes-specific enteral nutrition formula in hyperglycemic, mechanically ventilated, critically ill patients: a prospective, open-label, blind-randomized, multicenter study. Crit Care. 2015; 19:390.
30. Mottalib A, Mohd-Yusof BN, Shehabeldin M, Pober DM, Mitri J, Hamdy O. Impact of diabetes-specific nutritional formulas versus oatmeal on postprandial glucose, insulin, GLP-1 and postprandial lipidemia. Nutrients 2016. doi: 10.3390/nu8070443.
31. Huhmann MB, Smith KN, Schwartz SL, Haller SK, Irvin S, Cohen SS. Plasma glucose and insulin response to two oral nutrition supplements in adults with type 2 diabetes mellitus. BMJ Open Diabetes Res Care. 2016; 4:e000240.
32. Vaisman N, Lansink M, Rouws CH, van Laere KM, Segal R, Niv E, Bowling TE, Waitzberg DL, Morley JE. Tube feeding with a diabetes-specific feed for 12 weeks improves glycaemic control in type 2 diabetes patients. Clin Nutr. 2009; 28:549–55.
33. Craig LD, Nicholson S, SilVerstone FA, Kennedy RD. Use of a reduced-carbohydrate, modified-fat enteral formula for improving metabolic control and clinical outcomes in longterm care residents with type 2 diabetes: results of a pilot trial. Nutrition. 1998; 14:529–34.
34. Magnoni D, Rouws CH, Lansink M, van Laere KM, Campos AC. Long-term use of a diabetes-specific oral nutritional supplement results in a low-postprandial glucose response in diabetes patients. Diabetes Res Clin Pract. 2008; 80:75–82.
35. de Luis DA, Izaola O, de la Fuente B, Terroba MC, Cuellar L, Cabezas G. A randomized clinical trial with two doses of an enteral diabetes-specific suplements in elderly patients with diabetes mellitus type 2. Eur Rev Med Pharmacol Sci. 2013; 17:1626–30.
36. Han YY, Lai SR, Partridge JS, Wang MY, Sulo S, Tsao FW, Hegazi RA. The clinical and economic impact of the use of diabetes-specific enteral formula on ICU patients with type 2 diabetes. Clin Nutr 2016. doi: 10.1016/j.clnu.2016.09.027. [Epub ahead of print].
37. Blaauw R. The use of specialised enteral formulae for patients with diabetes mellitus. S Afr J Clin Nutr. 2010; 23(Suppl 1):S55–7.
Table 1.
Composition of oral nutritional supplements for patients with diabetes/glucose intolerance
XML Download